Cargando…

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity

OBJECTIVE: This study was designed to present our early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity (ROP) at a single institution over a 13-month-period. METHODS: A retrospective case series of eight children with ROP who received intravitrea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Ayesha E., Channa, Roomasa, Durrani, Jibran, Ali, Azam, Ahmad, Khabir
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934720/ https://www.ncbi.nlm.nih.gov/pubmed/20844684 http://dx.doi.org/10.4103/0974-9233.65500

Ejemplares similares

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
por: Kim, Rebecca, et al.
Publicado: (2014)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
por: Kara, Caner, et al.
Publicado: (2017)

Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity
por: Simmons, Michael, et al.
Publicado: (2021)

Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity
por: Seo, Eoi Jong, et al.
Publicado: (2018)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023)

Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity
por: Roohipoor, Ramak, et al.
Publicado: (2018)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
por: Bhat, Vishalakshi, et al.
Publicado: (2023)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
por: Tokgöz, Orhan, et al.
Publicado: (2013)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
por: Shrestha, Ruchi, et al.
Publicado: (2019)

One year follow-up of intravitreal bevacizumab injection in Aggressive Retinopathy of Prematurity at Indonesian national referral hospital: Case series
por: Yulia, Dian Estu, et al.
Publicado: (2022)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
por: Huang, Ching-Yen, et al.
Publicado: (2022)

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
por: Higashiyama, Tomoaki, et al.
Publicado: (2017)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata, Shumpei, et al.
Publicado: (2019)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
por: Gangwe, Anil Babanrao, et al.
Publicado: (2021)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhy, Srikant, et al.
Publicado: (2018)

Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2020)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Abrishami, Majid, et al.
Publicado: (2021)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015)

Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
por: Ji, Marco H, et al.
Publicado: (2020)

Comparison of Clinical Outcomes of Intravitreal Bevacizumab and Aflibercept in Type 1 Prethreshold Retinopathy of Prematurity in Posterior Zone II
por: Eftekhari Milani, Amir, et al.
Publicado: (2022)

Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016)

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r1svkkhqtjgn1jvutvlln8ppkf